239 related articles for article (PubMed ID: 23354877)
1. Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options.
Vink EE; de Jager RL; Blankestijn PJ
Curr Hypertens Rep; 2013 Apr; 15(2):95-101. PubMed ID: 23354877
[TBL] [Abstract][Full Text] [Related]
2. Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?
de Beus E; de Jager R; Joles JA; Grassi G; Blankestijn PJ
J Hypertens; 2014 Sep; 32(9):1751-61. PubMed ID: 24805954
[TBL] [Abstract][Full Text] [Related]
3. The sympathetic nervous system in chronic kidney disease.
Ewen S; Ukena C; Linz D; Schmieder RE; Böhm M; Mahfoud F
Curr Hypertens Rep; 2013 Aug; 15(4):370-6. PubMed ID: 23737218
[TBL] [Abstract][Full Text] [Related]
4. The role of sympathetic nervous system in the progression of chronic kidney disease in the era of catheter based sympathetic renal denervation.
Petras D; Koutroutsos K; Kordalis A; Tsioufis C; Stefanadis C
Curr Clin Pharmacol; 2013 Aug; 8(3):197-205. PubMed ID: 23173962
[TBL] [Abstract][Full Text] [Related]
5. The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease.
Sata Y; Schlaich MP
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):344-52. PubMed ID: 26740184
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
Hering D; Esler MD; Schlaich MP
EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
[TBL] [Abstract][Full Text] [Related]
7. Potential role of endurance training in altering renal sympathetic nerve activity in CKD?
Howden EJ; Lawley JS; Esler M; Levine BD
Auton Neurosci; 2017 May; 204():74-80. PubMed ID: 27908698
[TBL] [Abstract][Full Text] [Related]
8. Selective afferent renal denervation mitigates renal and splanchnic sympathetic nerve overactivity and renal function in chronic kidney disease-induced hypertension.
Veiga AC; Milanez MIO; Ferreira GR; Lopes NR; Santos CP; De Angelis K; Garcia ML; Oyama LM; Gomes GN; Nogueira FN; Carvalho PM; Campos RR; Bergamaschi CT; Nishi EE
J Hypertens; 2020 Apr; 38(4):765-773. PubMed ID: 31764582
[TBL] [Abstract][Full Text] [Related]
9. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
[TBL] [Abstract][Full Text] [Related]
10. Renal sympathetic denervation and renal physiology.
Kalaitzidis RG; Karasavvidou D; Siamopoulos KC
Curr Clin Pharmacol; 2013 Aug; 8(3):189-96. PubMed ID: 23173964
[TBL] [Abstract][Full Text] [Related]
11. Renal Denervation.
Singh RR; Denton KM
Hypertension; 2018 Sep; 72(3):528-536. PubMed ID: 30354761
[No Abstract] [Full Text] [Related]
12. Total renal denervation reduces sympathoexcitation to different target organs in a model of chronic kidney disease.
Veiga GL; Nishi EE; Estrela HF; Lincevicius GS; Gomes GN; Simões Sato AY; Campos RR; Bergamaschi CT
Auton Neurosci; 2017 May; 204():81-87. PubMed ID: 27932204
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of resistant hypertension in chronic kidney disease.
Campese VM
Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
[TBL] [Abstract][Full Text] [Related]
14. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J
J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757
[No Abstract] [Full Text] [Related]
15. Contribution of the Renal Nerves to Hypertension in a Rabbit Model of Chronic Kidney Disease.
Sata Y; Burke SL; Gueguen C; Lim K; Watson AMD; Jha JC; Eikelis N; Jackson KL; Lambert GW; Denton KM; Schlaich MP; Head GA
Hypertension; 2020 Nov; 76(5):1470-1479. PubMed ID: 32895021
[TBL] [Abstract][Full Text] [Related]
16. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.
Le Jemtel TH; Richardson W; Samson R; Jaiswal A; Oparil S
Curr Hypertens Rep; 2017 Feb; 19(2):18. PubMed ID: 28243928
[TBL] [Abstract][Full Text] [Related]
18. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.
Nishihara M; Takesue K; Hirooka Y
Auton Neurosci; 2017 May; 204():88-97. PubMed ID: 27729205
[TBL] [Abstract][Full Text] [Related]
19. Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation?
Hubens LE; Verloop WL; Joles JA; Blankestijn PJ; Voskuil M
Curr Hypertens Rep; 2013 Aug; 15(4):313-20. PubMed ID: 23754326
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology I: the kidney and the sympathetic nervous system.
de Jager RL; Blankestijn PJ
EuroIntervention; 2013 May; 9 Suppl R():R42-7. PubMed ID: 23732154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
